Evaluación de puntos críticos en el consumo de medicamentos anticonceptivos hormonales, en estudiantes de la Universidad Nacional de Colombia: sede Bogotá 2008-2012
Cargando...
Archivos
Autores
Sotelo González, Carmen Julia
Director
Tipo de contenido
Document language:
Español
Fecha
Título de la revista
ISSN de la revista
Título del volumen
Documentos PDF
Resumen
Las poblaciones humanas se exponen continuamente al consumo de medicamentos ya sea para recuperar o para mantener determinadas condiciones de vida, a través de un resultado terapéutico. Objetivo: Caracterizar y analizar los puntos críticos en el consumo de Anticonceptivos Hormonales (AH), en una población femenina universitaria. Materiales y Métodos: Estudio observacional, descriptivo: Los puntos críticos inherentes a la prescripción se evaluaron a partir del 46% -354- de las historias clínicas y del 100% de prescripciones físicas para un año y a partir de encuestas del 71% de prescriptores voluntarios, los puntos críticos relacionados al paciente se evaluaron a partir de encuestas del 21% de voluntarias respondientes y la calidad biofarmacéutica se estableció para tres marcas de AH mas prescrito en el área de salud Estudiantil de la Universidad Nacional. Resultados: Población entre 18 y 31 años; 91,46% soltera; 45,95% estrato socioeconómico 3; Respecto al patrón de prescripción: 97,32% Prescripción de AHC de los que el 39,08% son AOC de cuarta generación. La calidad terapéutica de la prescripción en las 17 condiciones médicas propias de la población, presentó un 82,357% de cumplimiento frente a CMEA de la OMS, el 17,65% prescribió ACH método categoría dos frente a AOPS de categoría I. Los principales desaciertos en cuanto a aspectos de forma indican que el 17,99% refieren algún error relacionado con la concentración, El DCI es empleado en un 98,8%. Respecto a las percepciones de uso: 76,79% no utilizan doble protección AH-condón (AB); el confía en el consejo médico para iniciar la TAC. Respecto al patrón de uso: El 38,24% ha tenido una exposición a anticonceptivos de entre 1 y dos años. Con los medicamentos sobrantes la conducta más común es dejarlo guardado con otros medicamentos en un 46,45%. Respecto a la adherencia: y al test de auto cumplimiento el 68,64% son no cumplidoras. Respecto a la percepción del programa: Hay un cumplimiento de los requisitos normativos en un 86%, se identifican fortalezas en el personal médico y administrativos y oportunidades de mejora en la difusión y cobertura del servicio. Respecto a la calidad Biofarmacéutica para intercambiabilidad de los anticonceptivos en estudio, se encontró que una marca si es intercambiable con el medicamento tomado de referencia y la otra no. Conclusiones: Se encontraron factores positivos como el cumplimiento frente a parámetros normativos; También se encontraron factores negativos como: baja adherencia, percepciones erróneas ante el uso simultaneo de AH-AB, actitudes negativas respecto a la disposición final de AH y falta de equivalencia terapéutica entre medicamentos del mismo principio activo.
Abstract. Human populations are continuously exposed to drug use to either recover or maintain certain living conditions, through a therapeutic result. Objective: To describe and analyze the critical points in the consumption of Hormonal Contraceptives (AH ) in a female college population. Materials and Methods: An observational, descriptive study: The critical points are inherent to the procedure were evaluated from 46% of the medical records -354- and 100% physical requirements for a year and from surveys of 71% of volunteers prescribers points related to critical patient surveys assessed from 21 % voluntary and biopharmaceutical quality was established for three brands of AH prescribed more in the area of Student health at the National University. Results: Population between 18 and 31 years; 91.46 % single; Socioeconomic 45.95% 3; Regarding the prescription pattern: Prescription AHC 97.32 % of which 39.08 % are fourth generation COCs . The therapeutic quality of prescribing in the population own 17 medical conditions , presented a 76.47 % compliance against the medical eligibility criteria for contraceptive use WHO. Main mistakes in terms of how aspects indicate that 17.99 % reported an error related to the concentration , the DCI is used in 98.8 %. For perceptions of usage: 76.79 % used no condom AH- double protection (AB ); the trust medical advice to start the TAC . Regarding the usage pattern : The 38.24% have had an exposure to contraceptives between 1 and two years. With leftover drugs the most common behavior is left stored with other medicines in a 46.45 %. Regarding adherence: test and the self fulfilling 68.64 % are non-compliant . Regarding the perception of the program : There is compliance with regulatory requirements by 86 % , strengths identified in the medical and administrative staff and opportunities for improvement in the dissemination and service coverage. Regarding the interchangeability of Biopharmaceutical quality contraceptives study found that if a brand is interchangeable with the reference drug taken and the other not . Conclusions : Positive factors as compliance against regulatory parameters were found ; Low adhesion , misperceptions before the simultaneous use of AH- AB, negative attitudes towards the disposal of AH and lack of therapeutic equivalence between drugs of the same active principle as negative factors were also found.
Abstract. Human populations are continuously exposed to drug use to either recover or maintain certain living conditions, through a therapeutic result. Objective: To describe and analyze the critical points in the consumption of Hormonal Contraceptives (AH ) in a female college population. Materials and Methods: An observational, descriptive study: The critical points are inherent to the procedure were evaluated from 46% of the medical records -354- and 100% physical requirements for a year and from surveys of 71% of volunteers prescribers points related to critical patient surveys assessed from 21 % voluntary and biopharmaceutical quality was established for three brands of AH prescribed more in the area of Student health at the National University. Results: Population between 18 and 31 years; 91.46 % single; Socioeconomic 45.95% 3; Regarding the prescription pattern: Prescription AHC 97.32 % of which 39.08 % are fourth generation COCs . The therapeutic quality of prescribing in the population own 17 medical conditions , presented a 76.47 % compliance against the medical eligibility criteria for contraceptive use WHO. Main mistakes in terms of how aspects indicate that 17.99 % reported an error related to the concentration , the DCI is used in 98.8 %. For perceptions of usage: 76.79 % used no condom AH- double protection (AB ); the trust medical advice to start the TAC . Regarding the usage pattern : The 38.24% have had an exposure to contraceptives between 1 and two years. With leftover drugs the most common behavior is left stored with other medicines in a 46.45 %. Regarding adherence: test and the self fulfilling 68.64 % are non-compliant . Regarding the perception of the program : There is compliance with regulatory requirements by 86 % , strengths identified in the medical and administrative staff and opportunities for improvement in the dissemination and service coverage. Regarding the interchangeability of Biopharmaceutical quality contraceptives study found that if a brand is interchangeable with the reference drug taken and the other not . Conclusions : Positive factors as compliance against regulatory parameters were found ; Low adhesion , misperceptions before the simultaneous use of AH- AB, negative attitudes towards the disposal of AH and lack of therapeutic equivalence between drugs of the same active principle as negative factors were also found.
Abstract
Palabras clave propuestas
Contraceptivos; Prescripción; Consumo; Drospirenona; Ciproterona; Adherencia; Medicamentos residuales; Estudios de utilización de medicamentos; Perfiles de disolución; Bioequivalencia; Intercambiabilidad; Contraceptives; Prescription; Drospirenone; Cyproterone; Adhesion; Residual medications; Drug utilization studies; Dissolution profiles; Bioequivalence; Interchangeability